TOFIDENCE FDA approval date

The FDA approved TOFIDENCE on 29 Sep 2023.

FDA approval date
29 Sep 2023

Drug identity has not yet been verified against registry records

Also recorded as TOCILIZUMAB-BAVI

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2023-09-29DayTOFIDENCEFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761354", "applicant_as_listed_by_fda": "BIOGEN MA", "brand_names": ["TOFIDENCE"], "active_ingredients": ["TOCILIZUMAB-BAVI"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20230929", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026